. Author manuscript; available in PMC: 2013 Sep 12.

Published in final edited form as: Am J Med. 2009 Jun 26;122(10):961.e7–961.13. doi: 10.1016/j.amjmed.2008.12.021

Table 2.

Predictors of Medication Discontinuation After Myocardial Infarction

	Statins (n=219)		Beta-blockers (n=248)		ACE Inhibitors/ARBs (n=180)
Variable	Hazard Ratio	95% CI	Hazard Ratio	95% CI	Hazard Ratio	95% CI
Age (per year increase)	1.01	0.99-1.02	1.00	0.99-1.02	1.00	0.99-1.02
Male sex	0.82	0.58-1.17	1.01	0.72-1.40	0.84	0.57-1.24
Current Smoker	1.20	0.81-1.77	1.39	0.98-1.97	1.32	0.86-2.02
Received reperfusion or revascularization therapy	0.96	0.65-1.40	0.80	0.57-1.14	0.96	0.62-1.49
Enrolled in cardiac rehabilitation program	0.66	0.45-0.92	0.70	0.49-0.98	0.70	0.45-1.10
^aNumber of comorbidities	1.04	0.93-1.16	1.00	0.90-1.11	1.00	0.88-1.13

Determined from comorbidities used to calculate the Charlson comorbidity index

ACE-I/ARB= angiotensin converting enzyme inhibitor/ angiotensin II receptor blocker